1-2 of 2
Dana B. Willis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Feasibility of Administration of High Doses of Ex Vivo Expanded NK Cells for Prevention of Disease Relapse after Transplantation for Patients with Myeloid Malignancies - Final Results of a Phase I Clinical Trial

Stefan O. Ciurea, MD, Dean A. Lee, MD PhD, Cecele Denman, MS, Jolie Schafer, Roland L Bassett, Jr., Kai Cao, MS, MD, Gabriela Rondon, MD, Julianne Chen, Doris Soebbing, Dana B. Willis, Sairah Ahmed, MD, Qaiser Bashir, MD, Partow Kebriaei, MD, Issa F. Khouri, MD, Betul Oran, MD, Simrit Parmar, MD, Uday R. Popat, MD, Chitra Hosing, MD, Eric Yvon, PhD, Katayoun Rezvani, MD PhD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2016) 128 (22): 500.
https://doi.org/10.1182/blood.V128.22.500.500
Published: 2016
Journal Articles

Phase I Trial of IL-21 Ex Vivo Expanded NK Cells Administration to Prevent Disease Relapse after Haploidentical Stem-Cell Transplantation for Myeloid Leukemias

Stefan O. Ciurea, MD, Dean A. Lee, MD PhD, Kai Cao, MS, MD, Gabriela Rondon, MD, Julianne Chen, Dana B. Willis, Sairah Ahmed, MD, Eric Yvon, PhD, Katayoun Rezvani, MDPhD, Elizabeth J. Shpall, MD, Richard E. Champlin, MD
Journal: Blood
Blood (2015) 126 (23): 102.
https://doi.org/10.1182/blood.V126.23.102.102
Published: 2015